SyncoZymes

iindaba

Iindaba ezimnandi: I-Shangke Bio iye yamkelwa njengeprojekthi yokuguqulwa kwempumelelo yobuchwepheshe obuphezulu

Ngomhla we-5 kaJanuwari, i-2021, i-Shangke Biopharmaceutical (i-Shanghai) Co., Ltd. yanikezelwa nge-"(S) -1-tert-butoxycarbonyl-3-hydroxypiperidine" i-Shanghai High-tech Achievement Transformation Project.

Njengeshishini lesizwe lobuchwepheshe obuphezulu, iSuntech Biotech ihlala ithatha i-biotechnology ukukhokela uphuhliso lweshishini lemichiza kunye namayeza, kwaye izisa uhlaza nempilo ebantwini njengomsebenzi wayo.Ukwandisa ishishini ngeendlela ezininzi, ukusebenzisana ngenkuthalo nezikolo ezaziwayo-kakuhle kunye namashishini asekhaya nakwamanye amazwe, rhoqo ukuphuhlisa isakhono salo sophuhliso, ukwandisa ubumbeko lwangaphakathi lweshishini, kwaye ube ngcono kwaye womelele.

impumelelo yobuchwepheshe obuphezulu

Igama leprojekthi: (S) -1-tert-Butoxycarbonyl-3-hydroxypiperidine
Inombolo yomthetho: 202010694
Inqanaba lento: B
Ingaba kukho impumelelo kwintsimi yobuchwepheshe obuphezulu kunye namalungelo azimeleyo epropathi enomgangatho ophezulu wokuqonda: Ewe

Isicelo: (S) -1-tert-butoxycarbonyl-3-hydroxypiperidine (CAS: 143900-44-1) yinto ebalulekileyo ye-chiral ephakathi kwi-synthesis ye-ibrutinib APIs.I-Ibrutinib iyeza elitsha le-anticancer elijoliswe kwi-B-cell malignancies evunyiweyo phantsi kokuvunywa okukhawulezileyo yi-US Food and Drug Administration (FDA) ngoNovemba 13, i-2013 yonyango lwe-lymphoma.

Inkcazo yenguqu yempumelelo yobuchwepheshe obuphezulu
Ukuguqulwa kweempumelelo zobugcisa obuphezulu kubhekiselele kwinkqubo apho amashishini enza imveliso ephezulu kunye nomsebenzi.Urhulumente uyawaxhasa amashishini ukuba aphumeze inguqu kwiimpumelelo zenzululwazi nezobuchwepheshe ngophando oluzimeleyo nophuhliso, ukunika iilayisensi, ukuthatha izabelo ngexabiso, nokusebenzisana namashishini, iiyunivesithi kunye namaziko ophando.Kwiiprojekthi zenguqu yempumelelo yobuchwepheshe obuphezulu ejongiwe kwaye inikwe ingxelo lishishini, ngokugqitywa kwezalathi zayo ezibanzi zoqoqosho kunye neempawu zamalungelo epropathi yengqondo yeprojekthi, inqanaba lokusungula izinto ezintsha, njl. njl., utyalo-mali lwayo lwe-R&D lunxulumene neprojekthi. -amalungelo anxulumene nepropathi enomgangatho ophezulu wokuqonda, izatifikethi zelungelo elilodwa lomenzi wechiza, okanye abo bangena kwinqanaba leemviwo ezibambekayo.Isatifikethi sembeko esikhutshwe kwishishini emva kophononongo olungqongqo kunye nophando olucokisekileyo lwemarike, njengezixhobo zobungqina bokwenziwa kwesicelo selungelo elilodwa lomenzi wechiza, imodeli eluncedo yesatifikethi selungelo elilodwa lomenzi wechiza, isatifikethi sobhaliso lwesoftware, isatifiketi soyilo loyilo lwesekethe ehlanganisiweyo, njl.

Iprofayile yekhampani
I-Shangke Biomedical (i-Shanghai) Co., Ltd. yasekwa kwi-2008 kwaye ifumaneka kwi-International Medical Park, indawo esemazantsi yeZhangjiang Hi-Tech Park, ePudong, eShanghai.Yinkxaso-mali epheleleyo ye-Zhejiang Shangke Biomedical Co., Ltd. I-Shangke Bio izinikele kuphando kunye nophuhliso lweyona ndawo iphezulu yamayeza aluhlaza, ikhokelela kuphuhliso loshishino lwamachiza kunye ne-biotechnology eluhlaza, kwaye ibonelela ngezinto ezintsha. iimveliso kunye neenkonzo ezikumgangatho ophezulu kushishino lwamayeza.Lishishini lobuchwepheshe obuphezulu eShanghai kunye neshishini lobuchwepheshe obuphezulu laseShanghai "elikhethekileyo, elisulungekileyo, elikhethekileyo nelitsha".

Ishishini eliphambili le-Suntech libandakanya: ukuphuhliswa kunye nokusetyenziswa kwe-enzymes ye-biological, ukuphuhliswa kunye nokuveliswa kwe-pharmaceutical intermediates, i-APIs kunye neekhemikhali ezisebenzayo.Iimveliso eziphambili zenkampani zimveliso ze-coenzyme, kubandakanya i-NMN, i-NAD, i-NADP, i-NADH, i-NADPH, i-enzymes yebhayoloji, izinto ezikrwada zamayeza kunye neziphakathi.Abathengi bale nkampani kunye namaqabane kwihlabathi liphela, kwaye yenze ubudlelwane obusondeleyo bentsebenziswano kunye neenkampani ezininzi zamayeza eMntla Melika, eYurophu, eIndiya naseTshayina.


Ixesha lokuposa: Jan-15-2021